Anti-tumor activity of all-trans retinoic acid-incorporated glycol chitosan nanoparticles against HuCC-T1 human cholangiocarcinoma cells

International Journal of Pharmaceutics

Volumn 422, Issue 1-2, 2012, Pages 454-461

  Chung, Kyu Don ^a   Jeong, Young Il ^b   Chung, Chung Wook ^b   Kim, Do Hyung ^b   Kang, Dae Hwan ^b  

^a The Catholic University of Korea   (South Korea)

^b Pusan National University   (South Korea)

Author keywords

All trans retinoic acid; Cholangiocarcinoma; Glycol chitosan; Invasion; Nanoparticles

Indexed keywords

AMINE; CHITOSAN; GLYCOL; MATRIGEL; NANOPARTICLE; RETINOIC ACID;

ANTINEOPLASTIC ACTIVITY; APOPTOSIS; AQUEOUS SOLUTION; ARTICLE; BILE DUCT CARCINOMA; CANCER INVASION; CARCINOMA CELL; CELL DEATH; CELL MIGRATION; CELL PROLIFERATION; CYTOTOXICITY; FLOW CYTOMETRY; HUMAN; HUMAN CELL; PARTICLE SIZE; PRIORITY JOURNAL; SERUM GROUP GC SYSTEM; STATIC ELECTRICITY; WOUND HEALING;

ANTINEOPLASTIC AGENTS; APOPTOSIS; BILE DUCT NEOPLASMS; BILE DUCTS, INTRAHEPATIC; CELL LINE, TUMOR; CELL MOVEMENT; CELL PROLIFERATION; CELL SURVIVAL; CHEMISTRY, PHARMACEUTICAL; CHITOSAN; CHOLANGIOCARCINOMA; DOSE-RESPONSE RELATIONSHIP, DRUG; DRUG CARRIERS; DRUG COMPOUNDING; HUMANS; NANOPARTICLES; NANOTECHNOLOGY; NECROSIS; NEOPLASM INVASIVENESS; PARTICLE SIZE; TECHNOLOGY, PHARMACEUTICAL; TRETINOIN;

EID: 84655164879     PISSN: 03785173     EISSN: 18733476     Source Type: Journal    
DOI: 10.1016/j.ijpharm.2011.10.057     Document Type: Article

References (44)

1. Y. Adachi, F. Itoh, H. Yamamoto, S. Iku, K. Matsuno, Y. Arimura, and K. Imai Retinoic acids reduce matrilysin (matrix metalloproteinase 7) and inhibit tumor cell invasion in human colon cancer Tumour Biol. 22 2001 247 253 (Pubitemid 32588920)
2. B.R. Blechacz, and G.J. Gores Cholangiocarcinoma Clin. Liver Dis. 12 2008 131 150 (Pubitemid 351163138)
3. D.J. Bharali, M. Khalil, M. Gurbuz, T.M. Simone, and S.A. Mousa Nanoparticles and cancer therapy: a concise review with emphasis on dendrimers Int. J. Nanomed. 4 2009 1 7
4. H. Bouterfa, T. Picht, D. Keb, Mc.S.C. Herbold, E. Noll, P.M. Black, K. Roosen, and J.C. Tonn Retinoids inhibit human glioma cell proliferation and migration in primary cell cultures but not in established cell lines Neurosurgery 46 2000 419 430 (Pubitemid 30094480)
5. M.R. Bhuiya, Y. Nimura, J. Kamiya, S. Kondo, N. Hayakawa, and S. Shionoya Clinicopathologic studies on perineural invasion of bile duct carcinoma Ann. Surg. 215 1992 344 349
6. N. Chansri, S. Kawakami, F. Yamashita, and M. Hashida Inhibition of liver metastasis by all-trans retinoic acid incorporated into O/W emulsions in mice Int. J. Pharm. 321 2006 42 49 (Pubitemid 44247410)
7. P. Charoensit, S. Kawakami, Y. Higuchi, F. Yamashita, and M. Hashida Enhanced growth inhibition of metastatic lung tumors by intravenous injection of ATRA-cationic liposome/IL-12 pDNA complexes in mice Cancer Gene Ther. 17 2010 512 522
8. Y. Choi, S.Y. Kim, S.H. Kim, K.S. Lee, C. Kim, and Y. Byun Long-term delivery of all-trans-retinoic acid using biodegradable PLLA/PEG-PLLA blended microspheres Int. J. Pharm. 215 2001 67 81 (Pubitemid 32206605)
9. B.A. Conley, M.J. Egorin, R. Sridaha, R. Finley, R. Hemady, S. Wu, N.S. Tait, and D.A. Van Echo Phase I clinical trial of all-trans-retinoic acid with correlation of its pharmacokinetics and pharmacodynamics Cancer Chem. Pharm. 39 1997 291 299 (Pubitemid 27047473)
10. G.L. Defer, H. Adle-Biassette, F. Ricolfi, L. Martin, F.J. Authier, C. Chomienne, L. Degos, and J.D. Degos All-trans retinoic acid in relapsing malignant gliomas: clinical and radiological stabilization associated with the appearance of intratumoral calcifications J. Neurooncol. 34 1997 169 177 (Pubitemid 27271723)
11. E.H. Estey, F.J. Giles, H. Kantarjian, S. O'Brien, J. Cortes, E.J. Freireich, G. Lopez-Berestein, and M. Keating Molecular remissions induced by liposomal-encapsulated all-trans retinoic acid in newly diagnosed acute promyelocytic leukemia Clin. Observ. Interv. Ther. 94 1999 2230 2235 (Pubitemid 29467669)
12. S.R. Frankel, A. Eardley, G. Lauwers, M. Weiss, and R.P. Warrell The "retinoic acid syndrome" inacute promyelocytic leukemia Ann. Intern. Med. 117 1992 292 296
13. F. Giannini, R. Maestro, T. Vukosa, T. Vljevic, F. Pomponi, and M. Boiocchi All-trans, 13-cis and 9-cis retinoic acids induce a fully reversible growth inhibition in HNSCC cell lines: implications for in vivo retinoic acid use Int. J. Cancer 70 1997 194 200 (Pubitemid 27107417)
14. G.G. Giordano, M.F. Refojo, and M.H. Arroyo Sustained delivery of retinoic acid from microspheres of biodegradable polymer in PVR Invest. Ophtal. Vis. Sci. 34 1993 2743 2751 (Pubitemid 23232484)
15. E.J. Huang, Y.C. Ye, S.R. Chen, J.R. Chai, J.X. Lu, L. Zhoa, L.J. Gu, and Z.Y. Wang Use of all-trans retinoic acid in the treatment of acute promyelocytic leukemia Blood 72 1988 567 572
16. K.K. Jain Nanotechnology-based drug delivery for cancer Technol. Cancer Res. Treat. 4 2005 407 416 (Pubitemid 41242614)
17. Y.I. Jeong, S.H. Kim, T.Y. Jung, I.Y Kim, S.S. Kang, Y.H. Jin, H.H. Ryu, H.S. Sun, S.G. Jin, K.K. Kim, K.Y. Ahn, and S. Jung Polyion complex micelles composed of all-trans retinoic acid and poly(ethylene glycol)-grafted chitosan J. Pharm. Sci. 95 2006 2348 2360 (Pubitemid 44726376)
18. S.G. Jin, Y.I. Jeong, S. Jung, H.H. Ryu, Y.H. Jin, and I.Y. Kim The effect of hyaluronic acid on the invasiveness of malignant glioma cells: comparison of invasion potential at hyaluronic acid hydrogel and matrigel J. Korean Neurosurg. Soc. 46 2009 472 478
19. G.P. Kalmekerian, R.K. Jasti, P. Celano, B.D. Nelkin, and M. Marby All-trans retinoic acid alters myc gene expression and inhibits in vitro progression in small-cell lung cancer Cell Growth Differ. 5 1994 55 60 (Pubitemid 24256934)
20. C.H. Kim, C.W. Chung, K.H. Choi, J.J. Yoo, D.H. Kim, Y.I. Jeong, and D.H. Kang Effect of 5-aminolevulinic acid-based photodynamic therapy via reactive oxygen species in human cholangiocarcinoma cells Int. J. Nanomed. 6 2011 1357 1363
21. K. Kim, J.H. Kim, H. Park, Y.S. Kim, K. Park, H. Nam, S. Lee, J.H. Park, R.W. Park, I.S. Kim, K. Choi, S.Y. Kim, K. Park, and I.C. Kwon Tumor-homing multifunctional nanoparticles for cancer theragnosis: simultaneous diagnosis, drug delivery, and therapeutic monitoring J. Control Release 146 2010 219 227
22. G. Krupitza, W. Hulla, H. Harant, E. Dittrich, E. Kallay, and H. Huber Retinoic acid induced death of ovarian carcinoma cells correlates with c-myc stimulation Int. J. Cancer 61 1995 649 659
23. P.A. Lehman, J.T. Slattery, and T.J. Franz Percutaneous absorption of retinoids: influence of vehicle, light exposure, and dose J. Invest. Dermatol. 91 1988 56 61
24. J.H. Lim Cholangiocarcinoma: morphologic classification according to growth pattern and imaging findings AJR Am. J. Roentgenol. 181 2003 819 827 (Pubitemid 37021861)
25. S.J. Lim, and C.K. Kim Formulation parameters determining the physicochemical characteristics of solid lipid nanoparticles loaded with all-trans retinoic acid Int. J. Pharm. 243 2002 135 146
26. G. Morris-Kay Retinoids in Normal Development and Teratogenesis 1992 Oxford Science Publications Oxford
27. J.R.F. Muindi, S.R. Frankel, W.H. Miller, A. Jakubowski, D.A. Scheinberg, C.W. Young, E. Dmitrovsky, and R.P. Warrell Continuous treatment with all-trans-retinoic acid causes a progressive reduction in plasma drug concentrations: implications for relapse and retinoid "resistance" in patients with acute promyelocytic leukemia Blood 79 1992 299 303
28. E. Noll, and R.H. Miller Regulation of oligodendrocyte differentiation: a role for retinoic acid in the spinal cord Development 120 1994 649 660 (Pubitemid 24071206)
29. A. Papi, G. Bartolini, K. Ammar, F. Guerra, A.M. Ferreri, P. Rocchi, and M. Orlandi Inhibitory effects of retinoic acid and IIF on growth, migration and invasiveness in the U87MG human glioblastoma cell line Oncol. Rep. 18 2007 1015 1021
30. S.B. Reddy, and T. Patel Current approaches to the diagnosis and treatment of cholangiocarcinoma Curr. Gastroenterol. Rep. 8 2006 30 37
31. J. Rosai Ackerman's Surgical Pathology 8th ed. 1996 St. Louis, Mosby, pp. 914-915
32. R. Rotan Retinoids as modulators of tumor cell invasion and metastasis Semin. Cancer Biol. 2 1991 197 208
33. D.S. Sandhu, and L.R. Roberts Diagnosis and management of cholangiocarcinoma Curr. Gastroenterol. Rep. 48 2008 43 52
34. F.Z. Shen, B.Y. Zhang, Y.J. Feng, Z.X. Jia, B. An, C.C. Liu, X.Y. Deng, A.D. Kulkarni, and Y. Lu Current research in perineural invasion of cholangiocarcinoma J. Exp. Clin. Cancer Res. 29 2010 24
35. R. Sinha, G.J. Kim, S. Nie, and D.M. Shin Nanotechnology in cancer therapeutics: bioconjugated nanoparticles for drug delivery Mol. Cancer Ther. 5 2006 1909 1917 (Pubitemid 44336561)
36. P. Singh, and T. Patel Advances in the diagnosis, evaluation and management of cholangiocarcinoma Curr. Opin. Gastroenterol. 22 2006 294 299 (Pubitemid 44090067)
37. A.E. Sirica Cholangiocarcinoma: molecular targeting strategies for chemoprevention and therapy Hepatology 41 2005 5 15 (Pubitemid 40066375)
38. S. Suzuki, S. Kawakami, N. Chansri, F. Yamashita, and M. Hashida Inhibition of pulmonary metastasis in mice by all-trans retinoic acid incorporated in cationic liposomes J. Control Release. 116 2006 58 63 (Pubitemid 44792300)
39. E.Z. Szuts, and F.I. Harosi Solubility of retinoids in water Arch. Biochem. Biophys. 287 1991 297 304
40. A.F. Thünemann, and J. Beyermann Polyethyleneimine complexes with retinoic acid: structure, release profiles, and nanoparticles Macromolecules 33 2000 6878 6885
41. A.F. Thünemann, J. Beyermann, and H. Kukula Poly(ethylene oxide)-b-poly(l-lysine) complexes with retinoic acid Macromolecules 33 2000 5906 5911
42. T.M. Welzel, K.A. McGlynn, A.W. Hsing, T.R. O'Brien, and R.M. Pfeiffer Impact of classification of hilar cholangiocarcinomas (Klastskin tumors) on the incidence of intra- and extrahepatic Cholangiocarcinoma in the United States J. Natl. Cancer Inst. 98 2006 873 875 (Pubitemid 43923444)
43. J.J. Wang, Z.W. Zeng, R.Z. Xiao, T. Xie, G.L. Zhou, X.R. Zhan, and S.L. Wang Recent advances of chitosan nanoparticles as drug carriers Int. J. Nanomed. 6 2011 765 774
44. H.S. Yoo, J.E. Lee, H. Chung, I.C. Kwon, and S.Y. Jeong Self-assembled nanoparticles containing hydrophobically modified glycol chitosan for gene delivery J. Control Release. 103 2005 235 243 (Pubitemid 40248575)